These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 224224)

  • 21. Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes.
    Nemerow GR; McNaughton ME; Cooper NR
    J Immunol; 1985 Nov; 135(5):3068-73. PubMed ID: 2995485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C3 receptors and membrane complement components on lymphocytes jointly cause binding of EAC.
    Dierich MP; Landen B
    Adv Exp Med Biol; 1979; 114():187-8. PubMed ID: 463638
    [No Abstract]   [Full Text] [Related]  

  • 23. The functional significance of surface structures on lymphocytes.
    Wigzell H
    Ann Immunol (Paris); 1973 Feb; 124(1):7-15. PubMed ID: 4353195
    [No Abstract]   [Full Text] [Related]  

  • 24. Polyclonal immunoglobulin secretion by human B lymphocytes exposed to Epstein-Barr virus in vitro.
    Kirchner H; Tosato G; Blaese RM; Broder S; Magrath IT
    J Immunol; 1979 Apr; 122(4):1310-3. PubMed ID: 221572
    [No Abstract]   [Full Text] [Related]  

  • 25. Receptors for immunoglobulin and complement on human alveolar macrophages.
    Reynolds HY; Atkinson JP; Newball HH; Frank MM
    J Immunol; 1975 Jun; 114(6):1813-9. PubMed ID: 1127229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell markers in lymphomas and leukemias.
    Bowman WP; Melvin S; Mauer AM
    Adv Intern Med; 1980; 25():391-425. PubMed ID: 6987847
    [No Abstract]   [Full Text] [Related]  

  • 27. Suppression of C3 rosette formation by serum from patients with systemic lupus erythematosus. A corollary of disease activity.
    Scheinberg MA; Israel Filho G; Mendes NF; Vertzman L
    J Rheumatol; 1978; 5(1):19-25. PubMed ID: 305960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Spontaneous rosette forming, Fc and complement receptor bearing lymphocytes in pediatric diseases].
    Eggers G; Kruse H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(1):14-21. PubMed ID: 88386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphocyte functions and subpopulation distribution in marmosets.
    Wallen WC; Claysmith AP; Cicmanec JL
    Primates Med; 1978; 10():184-92. PubMed ID: 417319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoglobulin-bearing and complement-receptor lymphocytes constitute the same population in human peripheral blood.
    Ehlenberger AG; McWilliams M; Phillips-Quagliata JM; Lamm ME; Nussenzweig V
    J Clin Invest; 1976 Jan; 57(1):53-6. PubMed ID: 1081992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Existence and differentiation of immunoglobulin, immunoglobulin receptor, and complement receptor on the lymphocyte surface--their immunobiological and immunopathological significance].
    Yoshida TO
    Nihon Rinsho; 1977 Apr; 35(4):1605-10. PubMed ID: 301950
    [No Abstract]   [Full Text] [Related]  

  • 32. The detection of membrane-associated complement components (C 3 and C 4) on circulating human normal and leukemic leukocytes and on cultured cells with monkey erythrocytes.
    Burns GF; Cawley JC
    Eur J Immunol; 1979 Oct; 9(10):791-6. PubMed ID: 118035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunological characterization of human chronic lymphatic leukaemia (author's transl)].
    Barboni F; Rovinetti C; Lombardo M; Beltrandi E; Di Marzio A; Tabacchi P; Di Primio R; Geraci L; Battista P; Torlontano G
    Haematologica; 1979 Apr; 64(2):159-72. PubMed ID: 112007
    [No Abstract]   [Full Text] [Related]  

  • 34. Surface markers on human B and T-lymphocytes. IX. Two-color immunofluorescence studies on the association between ebv receptors and complement receptors on the surface of lymphoid cell lines.
    Yefenof E; Klein G; Jondal M; Oldstone MB
    Int J Cancer; 1976 Jun; 17(6):693-700. PubMed ID: 181330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of feline T and B cells.
    Kuramochi T; Takeishi M; Ishida T; Kato K; Ishida M
    Am J Vet Res; 1987 Feb; 48(2):183-5. PubMed ID: 3493718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in expression of surface marker characteristics on Epstein-Barr virus-transformed human and simian lymphoid cell lines.
    Robinson JE; Andiman WA; Henderson E; Miller G
    Primates Med; 1978; 10():149-55. PubMed ID: 205852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C3 receptor. A marker of a thymus-dependent B-cell subpopulation.
    Arnaiz-Villena A; Playfair JH; Roitt IM
    Clin Exp Immunol; 1975 May; 20(2):375-8. PubMed ID: 1082391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein-Barr virus transformation of the cells.
    McConnell I; Klein G; Lint TF; Lachmann PJ
    Eur J Immunol; 1978 Jul; 8(7):453-8. PubMed ID: 211040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A simple rosette assay for demonstration of complement receptor sites using complement-coated zymosan beads.
    Huber Ch; Wigzell H
    Eur J Immunol; 1976 Jun; 5(6):432-5. PubMed ID: 1086242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of complement activation by cobra venom factor on the migration of T and B lymphocytes into rat thoracic duct lymph.
    Spry CJ; Lane JT; Vyakarnam A
    Immunology; 1977 Jun; 32(6):947-54. PubMed ID: 301855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.